openPR Logo
Press release

Codex Labs OTC Bia Eczema Relief Lotion Is Awarded Seal of Acceptance from National Eczema Association and Microbiome-Friendly Certification from MyMicrobiome

04-08-2025 11:04 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Codex Labs OTC Bia Eczema Relief Lotion Is Awarded Seal

San Jose, Calif. - April 8th, 2025 - Codex Labs [https://www.codexlabscorp.com/], a Silicon Valley skintech company, announced that its over-the-counter (OTC) Bia Eczema Relief [https://www.codexlabscorp.com/collections/eczema/products/bia-eczema-relief-lotion]Lotion [https://www.codexlabscorp.com/collections/eczema/products/bia-eczema-relief-lotion]has been awarded the Seal of Acceptance by the National Eczema Association (NEA). The NEA Seal of Acceptance Trademark highlights products that avoid ingredients known to irritate and that are suitable for the care of eczema or sensitive skin.

The Bia Eczema Relief Lotion has also achieved Microbiome-friendly certification, according to the MyMicrobiome Standard. It is the first eczema OTC topical to achieve this certification.

"We are thrilled that our products have been recognized as non-irritating for over 30 million Americans who suffer from eczema, as well as microbiome-safe. We remain dedicated to creating solutions that protect and restore the skin barrier while supporting the microbiome," says Dr. Barbara Paldus, Founder and CEO.

The BIA eczema relief lotion leverages the patent-pending BiaComplex 2.0 Trademark , a blend of biotech-made cellular extracts derived from terrestrial and marine plants. This novel combination of actives addresses hydration, skin barrier repair (both increased ceramide and structural protein production and itch reduction in distinct yet synergistically effective ways.

The Bia Eczema Relief Lotion is designed to be used with the Bia [https://www.codexlabscorp.com/collections/eczema/products/bia-unscented-soap] Unscented Soap [https://www.codexlabscorp.com/collections/eczema/products/bia-unscented-soap], the first vegan, MyMicrobiome-certified soap that also carries the NEA Seal of Acceptance. This "Eczema Essentials" set can also be combined with the Antu Skin Barrier Support supplement in a trio that addresses both gut and skin barrier integrity. The supplement provides L-histidine, an amino acid used by the body to produce filaggrin protein and natural moisturization factor to reinforce the skin barrier, as well as a novel antioxidant (M3Plus Trademark ) that helps address gut barrier inflammation and permeability.

This "Ditch the Itch" trio underwent a clinical trial on subjects having mild to moderate eczema (SCORAD = 34.5). The measured improvements in 8 weeks included:

*
93% reduction in eczema score (SCORAD) in 100% of subjects

*
88% reduction of itch in 97% of subjects

*
117% hydration increase in 91% of subjects

*
83% flakiness (desquamation) decrease in 97% of subjects

"The Ditch the Itch set was tested in a clinical study and performed well for managing moderate eczema. It is remarkable to think that these are over-the-counter products, available to everyone without a prescription," stated Dr. Peter Lio, a leading US expert in pediatric eczema and Codex Labs Medical Advisory Board member. He added: "Such clinical results demonstrate the importance of addressing skin conditions with both topicals and ingestibles in an integrative, inside-out approach."

About Codex Labs

Based in Silicon Valley and led by scientist Dr. Barb Paldus, Codex Labs is committed to creating highly effective, clinically proven, microbiome-supporting skin-gut-brain-biome solutions that contain potent, biotech-derived plant-based actives. Our products are focused on restoring/protecting the skin barrier, managing inflammation, and addressing skin conditions associated with aging, acne, eczema and psoriasis. The brand has been heralded by integrative dermatologists and naturopathic doctors for creating the next generation of effective, vegan, cruelty-free and sustainable dermaceutical solutions.

Media Contact
Company Name: Otter Public Relations
Contact Person: Anna Kate Womack
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=codex-labs-otc-bia-eczema-relief-lotion-is-awarded-seal-of-acceptance-from-national-eczema-association-and-microbiomefriendly-certification-from-mymicrobiome]
Phone: 7032323140
City: ORLANDO
State: FL
Country: United States
Website: http://www.otterpr.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Codex Labs OTC Bia Eczema Relief Lotion Is Awarded Seal of Acceptance from National Eczema Association and Microbiome-Friendly Certification from MyMicrobiome here

News-ID: 3961696 • Views:

More Releases from ABNewswire

Hypercholesterolemia Pipeline 2025: Innovative Clinical Advancements by 25+ Global Leaders - DelveInsight | Featuring companies such as Jiangsu HengRui Medicine Co., Ltd., Merck Sharp & Dohme LLC, Arr
Hypercholesterolemia Pipeline 2025: Innovative Clinical Advancements by 25+ Glob …
DelveInsight's, "Hypercholesterolemia- Pipeline Insight, 2025" report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Hypercholesterolemia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. With hypercholesterolemia reaching global epidemic proportions and contributing to comorbid conditions such as
Anaplastic Large Cell Lymphoma Pipeline 2025: Innovative Clinical Developments by 4+ Global Leaders - DelveInsight | Featuring companies such as Nuvalent, Tessa Therapeutics, PersonGen Biotherapeutics
Anaplastic Large Cell Lymphoma Pipeline 2025: Innovative Clinical Developments b …
DelveInsight's, "Anaplastic Large Cell Lymphoma - Pipeline Insight, 2025," report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Anaplastic Large Cell Lymphoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. With anaplastic large cell lymphoma (ALCL)
Metastatic Prostate Cancer Market: Epidemiology, Therapies, and Key Players - DelveInsight | Featuring companies such as AstraZeneca, Arvinas, Madison Vaccines, Phosplatin Therapeutics, Hinova Pharmac
Metastatic Prostate Cancer Market: Epidemiology, Therapies, and Key Players - De …
Metastatic Prostate Cancer companies are Bristol Myers Squibb, Merck, MacroGenics, Daiichi Sankyo, Seagen/Merck, Taiho Pharmaceutical, Modra Pharmaceuticals, Xencor, Point Biopharma, Lantheus Holdings, Zenith Epigenetics, Essa Pharma, Telix Pharmaceuticals, Kintor Pharmaceutical, AB Science, Eli Lilly and Company, Exelixis, and others. Emerging therapies for metastatic prostate cancer, including NUBEQA (darolutamide), ERLEADA (apalutamide), MGC018 (vobramitamab duocarmazine), Bavdegalutamide (ARV-110), and others, are expected to drive growth in the metastatic prostate cancer market in the coming
Cabinets 4 Less Mesa Brings Affordable Cabinet Solutions to East Valley Homeowners
Cabinets 4 Less Mesa Brings Affordable Cabinet Solutions to East Valley Homeowne …
Cabinets 4 Less Mesa, a cabinet store located at 535 W Iron Ave, Suite 129 in Mesa, AZ, offers affordable ready-to-assemble and semi-custom cabinetry for kitchens, bathrooms, and more. Serving homeowners and contractors across the East Valley, the store combines value, quality, and personalized service, making it a go-to resource for remodeling projects. Learn more at cabinets4lessaz.com MESA, AZ - September 30, 2025 - Cabinets 4 Less Mesa [https://cabinets4lessaz.com], a full-service

All 5 Releases


More Releases for Bia

Survey: 68% of Companies Still Skip BIA-Experts Warn of Risk
A BPX survey reveals 68% of companies skip Business Impact Assessment, risking disruption, revenue loss, and regulatory non-compliance. Recently, an industry survey conducted by Business Process Xperts (BPX) has disclosed shocking results: 68% of companies are not doing Business Impact Assessment (BIA) as part of their risk management planning ( https://businessprocessxperts.com/business-process-management-bpm-consulting/ ), or continuity planning initiatives. The consequence of this negligence means companies are leaving themselves open to disruptions, loss of
Codex Labs Introduces First Bia OTC: Eczema Relief Lotion
SAN JOSE, CA - Feb 25th, 2025 - Codex Labs (https://www.codexlabscorp.com/), a Silicon Valley skintech company, has launched the first of its Bia over-the-counter (OTC) topicals for eczema management. Bia, meaning "food" in Gaelic, is often paired with "nourishment" in Celtic philosophy. The BIA eczema lotion leverages the patent-pending BiaComplex 2.0 Trademark , a blend of biotech-made cellular extracts derived from terrestrial and marine plants. This novel combination of actives addresses
Hospital BC Introduces Bioelectrical Impedance Analysis (BIA) for Enhanced Patie …
Hospital BC in Tijuana, Mexico, led by Dr. Jalil Illan Fraijo, introduces Bioelectrical Impedance Analysis (BIA) to enhance patient care. BIA measures body composition, offering better insights into fat, muscle, and water mass compared to traditional methods like BMI. This non-invasive technology helps optimize bariatric care by reducing muscle loss risks, ensuring more precise treatment plans, and improving patient outcomes. Tijuana, Mexico - February 19, 2025 - Hospital BC, led by
Cloud based Information Governance Market to Witness Huge Growth by Key Players: …
According to Market Study Report, Cloud based Information Governance Market provides a comprehensive analysis of the Cloud based Information Governance Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team. Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5275651 The report provides a comprehensive analysis of company profiles listed below: - Ernst &
07-09-2020 | Health & Medicine
InBody
F45 select InBody as an exclusive global BIA device partner.
A partnership between world leaders in their industries will bring the science-backed InBody BIA devices and technology to F45 members around the world.    InBody and F45 have signed an exclusive deal to provide access to InBody BIA technology to all F45 clubs globally. This partnership will help bring F45 into a position to supply the science-backed InBody technology that is trusted globally to all of its members. After comprehensive testing and comparison analysis
ESPEN 2013: BIA completely accepted by nutritionists
Bioelectrical Impedance Analysis (BIA) is a topical issue in nutrition medicine. That was made clear by the crowds at the seca BIA Workshop “Bioelectrical Impedance Analysis in Malnutrition and Obesity: Meet the Experts” at ESPEN in Leipzig. Nutritionists were eager to hear research results and information about clinical application of BIA directly from the experts. The list of speakers read like a Who’s Who of researchers working in body composition